|By PR Newswire||
|February 24, 2014 01:58 PM EST||
MOUNTAIN VIEW, Calif., Feb. 24, 2014 /PRNewswire/ -- Omnicell, Inc., (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for health care providers, today announced OptiFlex™ 12.0 to improve supply management throughout health care facilities. The newest version of OptiFlex includes automated unique device identification (UDI) capabilities that seamlessly integrate into Omnicell's end-to-end supply management solution.
Ensuring patient safety is core to all Omnicell products and OptiFlex with UDI capture capability furthers this commitment. As the FDA mandates unique medical device labeling and tracking, OptiFlex not only manages product inventory at the point-of-use with a single bar code scan capture, but also integrates with the EHR to create an automated tracking record within the EHR so that clinical care teams, materials managers and HIPAA-cleared staff can quickly identify device information. Hospitals utilizing OptiFlex 12.0 will be able to provide improved patient device surveillance in the event that there is a clinical need to identify the device post-procedure.
Today at the annual HIMSS conference, Omnicell proudly congratulates OptiFlex 12.0 development partner Mercy, one of the nation's largest Catholic health systems, for receiving the 2014 Intelligent Hospital Award for their efforts to integrate UDI in their EHR and enable outcomes-based analysis. For the past year, Mercy has conducted a pilot project involving the implantation of stents in the cardiac cath lab. Utilizing OptiFlex supply solutions at the point of use, Mercy staff has been able to integrate patient custodial information directly into the EHR, and seamlessly connect with materials management systems to provide better visibility to product usage and inventory in the cath lab suite.
"It is a great honor to receive the 2014 Intelligent Hospital Award and be recognized for our commitment to delivering the best care to our patients," said Dr. Joseph Drozda, Mercy's director of outcomes research. "As part of our cath lab pilot project, OptiFlex enabled us to capture UDI at the point of care and make our device surveillance program a reality. We're hopeful that our hospital peers will learn from our experience and pursue implementation of the same kind of program that promotes patient safety and increases efficiency in the hospital."
"Omnicell is proud to bring innovation to our customers that continue to seek the best possible care for patients in the most effective and efficient manner," said Marga Ortigas-Wedekind, Omnicell executive vice president, global marketing and product development. "OptiFlex 12.0 will help meet the challenges of new FDA mandates and bring tighter control of inventory utilization with a single bar code scan. The work and recognition of Mercy today at HIMSS demonstrates how partnerships can work to deliver superb solutions."
OptiFlex can be seen this week at HIMSS at the Omnicell booth (#902) and is part of the Intelligent Hospital Pavilion. General availability of OptiFlex 12.0 is expected in 2014.
Mercy is the sixth largest Catholic health care system in the U.S. and serves more than 3 million people annually. Mercy includes 33 acute care hospitals, four heart hospitals, two children's hospitals, two rehab hospitals and one orthopedic hospital, nearly 700 clinic and outpatient facilities, 40,000 co-workers and more than 2,100 Mercy Clinic physicians in Arkansas, Kansas, Missouri and Oklahoma. Mercy also has outreach ministries in Louisiana, Mississippi and Texas. More about Mercy: www.mercy.net.
Since 1992, Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire healthcare continuum— from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
More than 2,800 Acute Care customers worldwide have utilized Omnicell's medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions to help reduce costly hospital readmissions. In addition, these solutions enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please visit www.omnicell.com.
OMCL - G
- All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, .
- Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc. OptiFlex is a trademark of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.
SOURCE Omnicell, Inc.